# US 2026/0077057 A1 · Nucleic acid carrier and method for administering nucleic acid

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0077057 A1
- Document ID: US20260077057A1
- Status: Published application
- Kind: A1
- Application number: 19/398,914
- Filed: 2025-11-24
- Published: 2026-03-19
- Earliest claimed: 2019-07-05
- Assignees: Tokyo Medical University
- Applicants: Tokyo Medical University
- Inventors: Masahiko KURODA; Masakatsu TAKANASHI; Shin-ichiro OHNO; Tomohiro UMEZU
- Web page: https://patentgrep.com/patent/US20260077057A1

## CPC

- A61K 9/5176: {Compounds of unknown constitution, e.g. material from plants or animals (oils, fats, waxes, shellac A61K9/5123)}
- A61K 48/0033: {the non-active part being non-polymeric}
- A61K 31/7105: Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links
- A61K 47/6911: {the form being a liposome}
- A61K 47/6925: {the form being a microcapsule, nanocapsule, microbubble or nanobubble}
- C12N 15/113: Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants C12N15/8218)}
- C12N 15/88: using microencapsulation, e.g. using {amphiphile} liposome vesicle
- C12N 15/87: Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N 2310/141: MicroRNAs, miRNAs
- C12N 2310/3515: Lipophilic moiety, e.g. cholesterol
- C12N 2320/32: Special delivery means, e.g. tissue-specific
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

Provided is a novel carrier for introducing a nucleic acid such as a siRNA into a cell. The carrier for a nucleic acid of the present invention includes vesicles from a plant in the family Malpighiaceae, and preferably vesicles derived from acerola. A method for administering a nucleic acid according to the present invention includes forming a conjugate of the carrier for a nucleic acid of the present invention and a nucleic acid and administering the conjugate.

## Claims

### Claim 1

A method for producing a delivery-type nucleic acid reagent comprising:
allowing a carrier for a nucleic acid and a nucleic acid to coexist in a liquid so as to form a conjugate of the carrier for a nucleic acid and the nucleic acid,
wherein the carrier comprises vesicles from a plant fruit in the family Malpighiaceae.

### Claim 2 (depends on 1)

The method according to claim 1, further comprising:
mixing and incubating the carrier for a nucleic acid and the nucleic acid in the liquid.

### Claim 3 (depends on 1)

The method according to claim 1, wherein the vesicles have been prepared by:
filtering juice of a plant in the Malpighiaceae family so as to obtain filtered juice;
separating vesicles from the filtered juice
by ultracentrifugation.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the plant in the family Malpighiaceae is an acerola plant species.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the vesicles have an average particle size of 30 to 400 nm.

### Claim 6

A method for administering a nucleic acid to a subject comprising:
administering to the subject a conjugate of a carrier for a nucleic acid and a nucleic acid,
wherein the carrier comprises vesicles from a plant fruit in the family Malpighiaceae, and
the conjugate has been formed by allowing the carrier for a nucleic acid and the nucleic acid to coexist.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the vesicles have been prepared by:
filtering juice of a plant in the Malpighiaceae family so as to obtain filtered juice;
separating vesicles from the filtered juice by ultracentrifuging the vesicles into pellets.

### Claim 8 (depends on 6)

The method according to claim 6, wherein the plant in the family Malpighiaceae is an acerola plant species.

### Claim 9 (depends on 6)

The method according to claim 6, wherein the vesicles have an average particle size of 30 to 400 nm.

### Claim 10 (depends on 6)

The method according to claim 6, wherein the administering is performed by in vivo administration or in vitro administration.

### Claim 11 (depends on 6)

The method according to claim 6, wherein the subject is a human.

### Claim 12 (depends on 6)

The method according to claim 6, wherein the subject is a non-human animal.

### Claim 13 (depends on 6)

The method according to claim 6, wherein the nucleic acid is a nucleic acid reagent for suppressing gene expression.
